These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17495358)

  • 1. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
    Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
    JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
    Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
    Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.
    Chetty R; Serra S
    Histopathology; 2008 Feb; 52(3):325-30. PubMed ID: 18269583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
    El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
    Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-papillary tumors of the pancreas: histopathology.
    Santini D; Poli F; Lega S
    JOP; 2006 Jan; 7(1):131-6. PubMed ID: 16407635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.
    Hav M; Lem D; Chhut SV; Kong R; Pauwels P; Cuvelier C; Piet P
    Malays J Pathol; 2009 Dec; 31(2):137-41. PubMed ID: 20514858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
    Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
    Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
    Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
    Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clear cell variant of solid pseudopapillary tumor of the pancreas: a previously unrecognized pancreatic neoplasm.
    Albores-Saavedra J; Simpson KW; Bilello SJ
    Am J Surg Pathol; 2006 Oct; 30(10):1237-42. PubMed ID: 17001153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
    Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
    Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology.
    Chetty R; Serra S
    Adv Anat Pathol; 2008 Jul; 15(4):234-40. PubMed ID: 18580099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.
    Tanaka Y; Kato K; Notohara K; Hojo H; Ijiri R; Miyake T; Nagahara N; Sasaki F; Kitagawa N; Nakatani Y; Kobayashi Y
    Cancer Res; 2001 Dec; 61(23):8401-4. PubMed ID: 11731417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid pseudopapillary tumor of the pancreas: emphasis on differential diagnosis from aggressive tumors of the pancreas.
    Aydiner F; Erinanç H; Savaş B; Erden E; Karayalçin K
    Turk J Gastroenterol; 2006 Sep; 17(3):219-22. PubMed ID: 16941259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
    Min Kim S; Sun CD; Park KC; Kim HG; Lee WJ; Choi SH
    J Surg Oncol; 2006 Oct; 94(5):418-25. PubMed ID: 16967453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
    Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
    Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.